BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 19903175)

  • 1. Investigation of papulopustular eruptions caused by cetuximab treatment shows altered differentiation markers and increases in inflammatory cytokines.
    Han SS; Lee M; Park GH; Bang SH; Kang YK; Kim TW; Lee JL; Chang HM; Ryu MH
    Br J Dermatol; 2010 Feb; 162(2):371-9. PubMed ID: 19903175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine alterations in lichen sclerosus: an immunohistochemical study.
    Farrell AM; Dean D; Millard PR; Charnock FM; Wojnarowska F
    Br J Dermatol; 2006 Nov; 155(5):931-40. PubMed ID: 17034521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of Tumor Response to Cetuximab and Panitumumab in 116 Patients and a Review of Approaches to Managing Skin Toxicity.
    Jaka A; Gutiérrez-Rivera A; López-Pestaña A; del Alcázar E; Zubizarreta J; Vildosola S; Arregui MA; Sarasqueta C; Lobo C; Tuneu A
    Actas Dermosifiliogr; 2015; 106(6):483-92. PubMed ID: 25798804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granulocyte colony-stimulating-factor-induced psoriasiform dermatitis resembles psoriasis with regard to abnormal cytokine expression and epidermal activation.
    Mössner R; Beckmann I; Hallermann C; Neumann C; Reich K
    Exp Dermatol; 2004 Jun; 13(6):340-6. PubMed ID: 15186319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of death (CD95/FAS), activation and adhesion (CD54) molecules on blast cells of acute myelogenous leukemias by TNF-alpha and IFN-gamma.
    Munker R; Andreeff M
    Cytokines Mol Ther; 1996 Sep; 2(3):147-59. PubMed ID: 9384699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-gamma promotes exaggerated cytokine production in keratinocytes cultured from patients with atopic dermatitis.
    Pastore S; Corinti S; La Placa M; Didona B; Girolomoni G
    J Allergy Clin Immunol; 1998 Apr; 101(4 Pt 1):538-44. PubMed ID: 9564808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The activation of natural killer cell effector functions by cetuximab-coated, epidermal growth factor receptor positive tumor cells is enhanced by cytokines.
    Roda JM; Joshi T; Butchar JP; McAlees JW; Lehman A; Tridandapani S; Carson WE
    Clin Cancer Res; 2007 Nov; 13(21):6419-28. PubMed ID: 17962339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycotrienin II, a translation inhibitor that prevents ICAM-1 expression induced by pro-inflammatory cytokines.
    Yamada Y; Tashiro E; Taketani S; Imoto M; Kataoka T
    J Antibiot (Tokyo); 2011 May; 64(5):361-6. PubMed ID: 21448188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of tumor necrosis factor-alpha and interferon-gamma on the growth of a human salivary gland cell line.
    Wu AJ; Kurrasch RH; Katz J; Fox PC; Baum BJ; Atkinson JC
    J Cell Physiol; 1994 Nov; 161(2):217-26. PubMed ID: 7962105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-gamma-induced ICAM-1 and CD40 expression, complete lack of HLA-DR and CD80 (B7.1), and inconsistent HLA-ABC expression in basal cell carcinoma: a possible role for interleukin-10?
    Kooy AJ; Prens EP; Van Heukelum A; Vuzevski VD; Van Joost T; Tank B
    J Pathol; 1999 Feb; 187(3):351-7. PubMed ID: 10398091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of cytokine in the induction of adhesion molecules on cultured human gingival fibroblasts.
    Takahashi K; Takigawa M; Takashiba S; Nagai A; Miyamoto M; Kurihara H; Murayama Y
    J Periodontol; 1994 Mar; 65(3):230-5. PubMed ID: 7513022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine modulation of human corneal epithelial cell ICAM-1 (CD54) expression.
    Yannariello-brown J; Hallberg CK; Häberle H; Brysk MM; Jiang Z; Patel JA; Ernst PB; Trocme SD
    Exp Eye Res; 1998 Oct; 67(4):383-93. PubMed ID: 9820785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine imbalance with increased production of interferon-alpha in psoriasiform eruptions associated with antitumour necrosis factor-alpha treatments.
    Seneschal J; Milpied B; Vergier B; Lepreux S; Schaeverbeke T; Taïeb A
    Br J Dermatol; 2009 Nov; 161(5):1081-8. PubMed ID: 19681863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sebaceous glands as the primary target of EGFR-inhibitors in the development of papulopustular eruption.
    Takata T; Tarutani M; Zouboulis CC; Sano S
    J Dermatol Sci; 2012 May; 66(2):165-8. PubMed ID: 22440861
    [No Abstract]   [Full Text] [Related]  

  • 15. Direct influences of pro-inflammatory cytokines (IL-1beta, TNF-alpha, IL-6) on the proliferation and cell-surface antigen expression of cancer cells.
    Kuninaka S; Yano T; Yokoyama H; Fukuyama Y; Terazaki Y; Uehara T; Kanematsu T; Asoh H; Ichinose Y
    Cytokine; 2000 Jan; 12(1):8-11. PubMed ID: 10623436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal expression of interleukin-6 and tumour necrosis factor-alpha in normal and immunoinflammatory skin states in humans.
    Oxholm A
    APMIS Suppl; 1992; 24():1-32. PubMed ID: 1567657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of inflammatory cytokines on the isolated human sebaceous infundibulum.
    Guy R; Kealey T
    J Invest Dermatol; 1998 Apr; 110(4):410-5. PubMed ID: 9540984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective regulation of ICAM-1 and major histocompatibility complex class I and II molecule expression on epidermal Langerhans cells by some of the cytokines released by keratinocytes and T cells.
    Chang CH; Furue M; Tamaki K
    Eur J Immunol; 1994 Nov; 24(11):2889-95. PubMed ID: 7957579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokines at different stratum corneum levels in normal and sodium lauryl sulphate-irritated skin.
    de Jongh CM; Verberk MM; Spiekstra SW; Gibbs S; Kezic S
    Skin Res Technol; 2007 Nov; 13(4):390-8. PubMed ID: 17908190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staphylococcus coagulase-positive skin inflammation associated with epidermal growth factor receptor-targeted therapy: an early and a late phase of papulopustular eruptions.
    Amitay-Laish I; David M; Stemmer SM
    Oncologist; 2010; 15(9):1002-8. PubMed ID: 20709888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.